MentionFox
Home › Layoffs › Y-mAbs Therapeutics, Inc.
SEC filings · Form 8-K, Item 2.05

Y-mAbs Therapeutics, Inc. layoffs and restructuring

Before you join, sell to or invest in Y-mAbs Therapeutics, Inc.

MentionFox check on Y-mAbs Therapeutics, Inc.: only 1 source on file so far (checked 14 November 2026). Run a full check before you rely on it. mentionfox.com/c/layoffs/y-mabs-therapeutics

  • Note: Layoff plan disclosed Jan 2025 (filing)

New since last check: Layoff plan disclosed Jan 2025 (filing, first seen 14 November 2026).

Check Y-mAbs Therapeutics, Inc. before you join, sell or invest Free, no sign-up: every record on file, each linked to its source.

What do you want to do about Y-mAbs Therapeutics, Inc.?

Every exit or restructuring plan Y-mAbs Therapeutics, Inc. reported on Form 8-K under Item 2.05: the filing's own words on employees affected, share of workforce, locations, charges and timing.

As of November 14, 2026, Y-mAbs Therapeutics, Inc. has reported one exit or restructuring plan to the SEC on Form 8-K under Item 2.05, the latest filed on January 10, 2025. No WARN notice under its name is on file in the states covered here (Form 8-K, January 10, 2025).

10 companies announced layoffs this week, 1 had other signals.

Companies cutting jobs this week. Before you unlock: the company, the number of employees and what is inside. After: every way we found to reach the company. No individual is named in a layoff.

UPWORK, INCannounced layoffs
PVH CORP. /DE/announced layoffs
Battellefiled a layoff notice for 15 employees
TidalHealth Primary Carefiled a layoff notice for 5 employees
Phunware, Inc.announced layoffs
Check one company free All companies that announced layoffs this week

Beryl Capital Management LLC also filed stake reports on 4 other companies ↓

Is this your company?

Owed money by them or selling to them? See the free Snapshot of Y-mAbs Therapeutics, Inc.

Free to see. No signup.

People from Y-mAbs Therapeutics, Inc. who say they are open to work

Only people who added themselves are listed here. Nobody is named because of a company announcement or a news story, and we have not checked what anyone says about themselves.

Loading the list…

Affected by the Y-mAbs Therapeutics, Inc. layoff? Add yourself to the open-to-work list, free
SEC filings1
Latest filing2025-01-10

Y-mAbs Therapeutics, Inc. reported 1 exit or restructuring plan on Form 8-K under Item 2.05. Each fact below is the filing's own sentence, quoted and linked. No WARN notice under this company's name is on file in the states covered here.

Did Y-mAbs Therapeutics have layoffs in 2025? What its filings say

Y-mAbs Therapeutics, Inc. (CIK 1722964) reported 1 exit or restructuring plan to the SEC on Form 8-K under Item 2.05. The sentences below are quoted from the filings as written.

Form 8-K filed 2025-01-10

Expected charges

As a result of the reduction in workforce and realignment plan, the Company expects to incur restructuring expenses of up to approximately $2.6 million, consisting predominantly of cash-related notice and severance payments of up to approximately $2.1 million and acceleration of stock-based compensation of up to approximately $0.5 million.

Timing

This percentage substantially reflects the following: first, a small adjustment of the DANYELZA commercial team to focus the team on potential growth opportunities within the GD2 market, and second the relocation of some SADA development functions to the United States from Denmark, with such reduction anticipated to be completed by the end of the second quarter of 2025.

Also on the record for Y-mAbs Therapeutics, Inc.

DateRecordFigureOur pageSource
November 14, 2025Stake report, Schedule 13G/A, by Beryl Capital Management LLC—5%+ stakesSource
November 14, 2025Stake report, Schedule 13G/A, by Caligan Partners LP—5%+ stakesSource
November 14, 2025Stake report, Schedule 13G/A, by HBM Healthcare Investments (Cayman) Ltd.—5%+ stakesSource
November 14, 2025Stake report, Schedule 13G/A, by Paradigm BioCapital Advisors LP—5%+ stakesSource
November 13, 2025Stake report, Schedule 13G/A, by Glazer Capital, LLC—5%+ stakesSource
August 20, 2025Stake report, Schedule 13G/A, by Anders Hove6.2% of the class5%+ stakesSource
August 15, 2025Stake report, Schedule 13G, by Glazer Capital, LLC5.84% of the class5%+ stakesSource
August 15, 2025Stake report, Schedule 13G/A, by Anders Hove7% of the class5%+ stakesSource
August 12, 2025Stake report, Schedule 13G, by Beryl Capital Management LLC9% of the class5%+ stakesSource

Keep reading

More on Y-mAbs Therapeutics, Inc. and the records around it.

Y-mAbs Therapeutics, Inc. elsewhere on the record

Companies that share a holder

What do you want to do with Y-mAbs Therapeutics, Inc.?

Want the whole picture on Y-mAbs Therapeutics, Inc.?

Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)

A Full Report on Y-mAbs Therapeutics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on Y-mAbs Therapeutics, Inc. covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    10 cited sources found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

Tools for this story

Each opens in a new tab, filled in for Y-mAbs Therapeutics, Inc.. With no account yet, you sign up free and land on the result.

Public companies must also report to the SEC, on Form 8-K under Item 2.05, when they commit to an exit or restructuring plan that will cost them material charges, which is how most large layoffs and closures by listed companies are disclosed. Those filings are national, so they cover companies in every state. Each sentence shown from one is quoted exactly and linked to the filing; where a filing does not state a figure, none is shown.

Where this comes from

Employers covered by the federal WARN Act, and by the stricter laws some states add, must give written notice before a mass layoff or a site closure. The state labor department publishes those notices. Every row here is one of them, taken from that state's own published file and linked to it, so each figure can be checked at the source.

A notice states the employer, the location, the number of employees affected, and when the layoff or closure takes effect. It does not state a reason, and neither does this page. Where a company also appears in SEC filings under the same name and in the same state, its recorded fundraising is shown alongside, as a matter of record rather than as an explanation. New Jersey and Pennsylvania list a notice under the month it was posted or received, not the day, so their notices show a month. Tennessee gives the county rather than the city.

Cite this page

Permanent URL: https://mentionfox.com/layoffs/y-mabs-therapeutics
Last updated 2026-11-14
Y-mAbs Therapeutics, Inc. layoffs and restructuring: 1 SEC filing (2025-01-10). MentionFox, 2026-11-14. https://mentionfox.com/layoffs/y-mabs-therapeutics